Literature DB >> 21794082

Immunosuppression, generic drugs and the FDA.

G B Klintmalm.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21794082     DOI： 10.1111/j.1600-6143.2011.03616.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  15 in total

1.  The adoption of generic immunosuppressant medications in kidney, liver, and heart transplantation among recipients in Colorado or nationally with Medicare part D.

Authors:  Qian Liu; Abigail R Smith; Jeong M Park; Murewa Oguntimein; Sarah Dutcher; Ghalib Bello; Margaret Helmuth; Marc Turenne; Rajesh Balkrishnan; Melissa Fava; Charlotte A Beil; Adam Saulles; Sangeeta Goel; Pratima Sharma; Alan Leichtman; Jarcy Zee
Journal:  Am J Transplant       Date:  2018-03-31       Impact factor: 8.086

2.  A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipients.

Authors:  R R Alloway; B Sadaka; J Trofe-Clark; A Wiland; R D Bloom
Journal:  Am J Transplant       Date:  2012-07-03       Impact factor: 8.086

Review 3.  Progress in abdominal organ transplantation.

Authors:  Maciej Kosieradzki; Wojciech Lisik; Wojciech Rowiński; Piotr Małkowski
Journal:  Med Sci Monit       Date:  2011-12

4.  Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients.

Authors:  Gere Sunder-Plassmann; Petra Reinke; Thomas Rath; Andrzej Wiecek; Michal Nowicki; Richard Moore; Jens Lutz; Martina Gaggl; Marek Ferkl
Journal:  Transpl Int       Date:  2012-04-16       Impact factor: 3.782

Review 5.  A Systematic Literature Review Approach to Estimate the Therapeutic Index of Selected Immunosuppressant Drugs After Renal Transplantation.

Authors:  Jessica E Ericson; Kanecia O Zimmerman; Daniel Gonzalez; Chiara Melloni; Jeffrey T Guptill; Kevin D Hill; Huali Wu; Michael Cohen-Wolkowiez
Journal:  Ther Drug Monit       Date:  2017-02       Impact factor: 3.118

Review 6.  Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod.

Authors:  Jorge Correale; Erwin Chiquete; Alexey Boyko; Roy G Beran; Jorge Barahona Strauch; Snezana Milojevic; Nadina Frider
Journal:  Drug Des Devel Ther       Date:  2016-06-30       Impact factor: 4.162

7.  Transplant coordinators' perceived impact of availability of multiple generic immunosuppression therapies on patients, workload, and posttransplant maintenance therapy.

Authors:  K Parker; E A Zagadailov; A S Bruno; A M Wiland
Journal:  J Transplant       Date:  2013-01-08

Review 8.  Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis.

Authors:  Amber O Molnar; Dean Fergusson; Anne K Tsampalieros; Alexandria Bennett; Nicholas Fergusson; Timothy Ramsay; Greg A Knoll
Journal:  BMJ       Date:  2015-06-22

Review 9.  Equivalence and interchangeability of narrow therapeutic index drugs in organ transplantation.

Authors:  Atholl Johnston
Journal:  Eur J Hosp Pharm       Date:  2013-08-29

10.  Systematic conversion to generic tacrolimus in stable kidney transplant recipients.

Authors:  Staffan Rosenborg; Annica Nordström; Tora Almquist; Lars Wennberg; Peter Bárány
Journal:  Clin Kidney J       Date:  2014-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.